Fennec Pharmaceuticals

FENC · NASDAQ

$10.46+$0.19 (+1.85%)TodayMarket closed ·
Prev close $10.27

Who owns FENC

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 52.3% of FENC’s shares.

  • ESSETIFIN S.p.A.11.5%
  • Rosalind Advisors, Inc.9.2%
  • Sonic GP LLC7.5%
  • Solas Capital Management, LLC5.4%
  • Next 6 largest institutions18.7%
  • All other shareholders47.7%
Top institutional holders of FENC
HolderShares% of shares
ESSETIFIN S.p.A.3.99M11.50%
Rosalind Advisors, Inc.3.19M9.18%
Sonic GP LLC2.61M7.51%
Solas Capital Management, LLC1.89M5.44%
AIGH Capital Management, LLC.1.85M5.33%
BlackRock Institutional Trust Company, N.A.1.50M4.31%
AWM Investment Company, Inc.1.16M3.34%
Vanguard Capital Management, LLC839.31K2.42%
Worth Venture Partners, LLC633.74K1.82%
Prospect Capital Advisors, LLC497.80K1.43%

Largest mutual fund holders

Top mutual fund holders of FENC
HolderShares% of shares
Vanguard Total Stock Market Index Fund815.19K2.35%
iShares Russell 2000 ETF750.22K2.16%
Fidelity Small Cap Index Fund314.60K0.91%
iShares Russell 2000 Growth ETF274.78K0.79%
Vanguard Russell 2000 Index Fund163.18K0.47%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $1.73M (9 trades) of FENC on the open market, with no buys.

Latest FENC insider transactions
InsiderTypeSharesValue
Cioffi Christiana MarieAward3.95K$21.82K
Sayad Pierre SargisAward3.85K$21.27K
Evans Terry LAward2.33K$12.86K
Hackman Jeffrey S.Award2.22K$12.30K
Andrade RobertAward3.85K$21.27K
Cioffi Christiana MarieAward156—
Sayad Pierre SargisAward168—
Evans Terry LAward168—
Hackman Jeffrey S.Award1.16K—
Andrade RobertAward1.70K—

Short interest

Settled Sep 30, 2026

Shares short
513.29K
Days to cover
3.85
% of shares outstanding
1.48%
Average daily volume
133.17K
Change since last report
−5.8%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.